Use of docetaxel in combination with octreotide as a synergistic combination for prostate cancer with apoptotic and antiangiogenic effects.
Burcak Karaca
No relevant relationships to disclose
Harika Atmaca
No relevant relationships to disclose
Emir Bozkurt
No relevant relationships to disclose
Canfeza Sezgin
No relevant relationships to disclose
Bulent Karabulut
No relevant relationships to disclose
Ruchan Uslu
No relevant relationships to disclose